Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › alcohol dependence

Alcohol dependence

Part of Alcohol Use Disorder

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for alcohol dependence

101 trials tracked for alcohol dependence: 48 in phase 3 or 4 and 1 with published results. The most-cited published study has 8 citations.

101Trials tracked
48Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 25 Phase 3 23 Phase 2 34 Phase 1 3 Other / NA 16
  1. Phase 3 Progesterone Effect on Individuals Diagnoses With AD and PTSD. Completed · 8 cited
  2. Phase 4 Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users Completed
  3. Phase 4 Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder Completed
  4. Phase 4 Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism Completed
  5. Phase 4 Quetiapine for Bipolar Disorder and Alcohol Dependence Completed
  6. Phase 4 Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder Completed
Show 44 more trials
  1. Phase 4 Pharmacogenetic Response to Naltrexone For Alcohol Dependence Completed
  2. Phase 4 Dutasteride Treatment for the Reduction of Heavy Drinking in Men Completed
  3. Phase 4 Zonisamide vs. Placebo in the Treatment of Alcohol Dependence Completed
  4. Phase 4 Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients Completed
  5. Phase 4 Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism Completed
  6. Phase 4 Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic Completed
  7. Phase 4 Extended-release Naltrexone for Alcohol Dependence in Primary Care Completed
  8. Phase 4 Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care Completed
  9. Phase 4 Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism Completed
  10. Phase 4 ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults Completed
  11. Phase 4 Treatment of Alcohol Dependence and Comorbid Bipolar Disorder Completed
  12. Phase 4 Dutasteride for the Reduction of Alcohol Use in Male Drinkers Completed
  13. Phase 4 Citicoline for Alcohol Dependence Completed
  14. Phase 4 Alcohol Disorder hOsPital Treatment Trial Completed
  15. Phase 4 Acamprosate in Alcoholics With Comorbid Anxiety or Depression Completed
  16. Phase 4 Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone) Completed
  17. Phase 4 Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. Completed
  18. Phase 4 Acamprosate vs. Placebo in Bipolar Alcoholics Completed
  19. Phase 4 A Randomized Clinical Trial of Alcohol Care Management Completed
  20. Phase 4 A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD Completed
  21. Phase 3 Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism Completed
  22. Phase 3 New Treatment for Alcohol and Nicotine Dependence Completed
  23. Phase 3 Effects of Omegas 3 and 6 on Alcohol Dependence Completed
  24. Phase 3 Gabapentin for Abstinence Initiation in Alcohol Dependence Completed
  25. Phase 3 Aripiprazole Effects on Alcohol Drinking and Craving Completed
  26. Phase 3 Glutamatergic Modulation of Disordered Alcohol Use Completed
  27. Phase 3 A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial) Completed
  28. Phase 3 Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence Completed
  29. Phase 3 Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD). Completed
  30. Phase 3 Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence Completed
  31. Phase 3 ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®) Completed
  32. Phase 3 A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence Completed
  33. Phase 3 Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism Completed
  34. Phase 3 Efficacy of Nalmefene in Patients With Alcohol Dependence Completed
  35. Phase 3 Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence Completed
  36. Phase 3 Varenicline Treatment for Active Alcoholic Smokers Completed
  37. Phase 3 Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone Completed
  38. Phase 3 ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence Completed
  39. Phase 3 Prometa Protocol for Alcohol Dependence Completed
  40. Phase 3 A New Pharmacotherapy for Alcohol Dependence: Olanzapine Completed
  41. Phase 3 Efficacy of Nalmefene in Patients With Alcohol Dependence Completed
  42. Phase 3 Treatment Strategy for Alcohol Use Disorders in Veterans With TBI Completed
  43. Phase 2 Mifepristone Treatment of Alcohol Use Disorder Completed
  44. Phase 2 ABT-436 for Alcohol Dependence Completed

Showing the 50 most-cited and recently-updated of 101 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.